Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The immune system in hearing disorders.

J E Veldman1

  • 1Department of Otorhinolaryngology, University of Utrecht, The Netherlands.

Acta Oto-Laryngologica. Supplementum
|January 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Ossicle Bank of the University Medical Centre (UMCU), The Netherlands.

Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery·2005
Same author

['Surgery by the red-haired barbarians'; Dutch physicians in Japan, 1600-1870].

Nederlands tijdschrift voor geneeskunde·2002
Same author

Fluoride therapy for cochlear otosclerosis? an audiometric and computerized tomography evaluation.

Acta oto-laryngologica·2001
Same author

Dose-dependent effect of 8-day cisplatin administration upon the morphology of the albino guinea pig cochlea.

Hearing research·2000
Same author

Cisplatin-induced ototoxicity: morphological evidence of spontaneous outer hair cell recovery in albino guinea pigs?

Hearing research·2000
Same author

Histological effects of co-administration of an ACTH((4-9)) analogue, ORG 2766, on cisplatin ototoxicity in the albino guinea pig.

Hearing research·2000
Same journal

Towards a consensus on a hearing preservation classification system.

Acta oto-laryngologica. Supplementum·2013
Same journal

Inner ear drug delivery system from the clinical point of view.

Acta oto-laryngologica. Supplementum·2010
Same journal

Hydrogen protects vestibular hair cells from free radicals.

Acta oto-laryngologica. Supplementum·2010
Same journal

Distribution of bone marrow-derived cells in the vestibular end organs and the endolymphatic sac.

Acta oto-laryngologica. Supplementum·2010
Same journal

Impacts and limitations of medialization thyroplasty on swallowing function of patients with unilateral vocal fold paralysis.

Acta oto-laryngologica. Supplementum·2010
Same journal

A tissue-engineering approach for stenosis of the trachea and/or cricoid.

Acta oto-laryngologica. Supplementum·2010
See all related articles

Immune responses can contribute to audiovestibular dysfunction, affecting the cochlear and retrocochlear pathways. While autoimmunity is involved, anti-inflammatory treatments are key for managing these hearing disorders.

Area of Science:

  • Otorhinolaryngology
  • Immunology
  • Neuroscience

Background:

  • Audiovestibular dysfunction encompasses hearing and balance disorders.
  • Cellular and humoral immune reactions are implicated in the development of these dysfunctions.
  • Immune-mediated inner ear disorders can originate from cochlear or retrocochlear sites.

Purpose of the Study:

  • To explore the role of immune reactions in the pathogenesis of audiovestibular dysfunction.
  • To discuss the origins and management of immune-mediated inner ear disorders.
  • To highlight these conditions as 'experiments of nature' for research.

Main Methods:

  • Review of existing literature on immune responses and audiovestibular disorders.
  • Analysis of the ethiopathogenesis of cochlear and retrocochlear immune-mediated conditions.

Related Experiment Videos

  • Discussion of therapeutic strategies, particularly anti-inflammatory treatments.

    • Main Results:

    • Immune reactions, including autoimmunity, are significant factors in audiovestibular dysfunction.
    • Both cochlear and retrocochlear pathways can be affected by immune-mediated processes.
    • Anti-inflammatory therapy is the primary treatment approach.

    Conclusions:

    • Immune mechanisms are crucial in audiovestibular dysfunction.
    • Understanding these disorders offers insights into auditory and vestibular system function.
    • Further research into immune-mediated hearing loss is warranted.